Detalhe da pesquisa
1.
Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies.
Proc Natl Acad Sci U S A
; 116(1): 227-232, 2019 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30518559
2.
Severe Dengue Epidemic, Sri Lanka, 2017.
Emerg Infect Dis
; 26(4): 682-691, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32186490
3.
Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris.
BMC Biotechnol
; 16: 12, 2016 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26847361
4.
A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture.
Virol J
; 12: 16, 2015 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25886260
5.
Dengue-specific subviral nanoparticles: design, creation and characterization.
J Nanobiotechnology
; 11: 15, 2013 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-23706089
6.
Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals.
mSphere
; 6(4): e0027521, 2021 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34431693
7.
Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individuals.
medRxiv
; 2021 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33564775
8.
Convalescent Plasma Therapy in Four Critically Ill Pediatric Patients With Coronavirus Disease 2019: A Case Series.
Crit Care Explor
; 2(10): e0237, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33063037
9.
The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients.
Sci Immunol
; 5(48)2020 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32527802
10.
The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies.
medRxiv
; 2020 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32511572
11.
A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice.
PLoS Negl Trop Dis
; 12(1): e0006191, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29309412
12.
Erratum for Markmann et al., "Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals".
mSphere
; 6(5): e0073621, 2021 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34494885
13.
Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies.
Front Microbiol
; 6: 1005, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26441930
14.
Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes.
PLoS Negl Trop Dis
; 9(12): e0004255, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26709822
15.
Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies.
PLoS One
; 8(5): e64595, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23717637
16.
Pichia pastoris-expressed dengue virus type 2 envelope domain III elicits virus-neutralizing antibodies.
J Virol Methods
; 167(1): 10-6, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20211204
17.
An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes.
Am J Trop Med Hyg
; 79(3): 353-63, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18784226